Have a feature idea you'd love to see implemented?
Let us know!
WVE Wave Life Sciences Ltd
Price (delayed)
$14.82
Market cap
$1.85B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.57
Enterprise value
$1.72B
Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using
Highlights
Wave Life Sciences's debt has decreased by 18% YoY and by 5% QoQ
The equity has plunged by 114% from the previous quarter but it has soared by 93% YoY
Wave Life Sciences's EPS has soared by 57% YoY but it has decreased by 10% from the previous quarter
The quick ratio fell by 27% YoY and by 17% QoQ
Wave Life Sciences's revenue has decreased by 2.1% QoQ
Key stats
What are the main financial stats of WVE
Market
Valuations
Earnings
Shares outstanding
124.74M
Market cap
$1.85B
Enterprise value
$1.72B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
17.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.6
Revenue
$110.5M
EBIT
-$74.16M
EBITDA
-$65.37M
Free cash flow
-$129.62M
Per share
Balance sheet
Liquidity
EPS
-$0.57
Free cash flow per share
-$1
Book value per share
-$0.03
Revenue per share
$0.85
TBVPS
$1.61
Total assets
$208.82M
Total liabilities
$204.42M
Debt
$28.88M
Equity
-$3.48M
Working capital
-$1.05M
Debt to equity
-8.3
Current ratio
0.99
Quick ratio
0.9
Net debt/EBITDA
1.91
Margins
Efficiency
Dividend
EBITDA margin
-59.2%
Gross margin
100%
Net margin
-66.5%
Operating margin
-75.7%
Return on assets
-32.1%
Return on equity
-1,400.9%
Return on invested capital
N/A
Return on capital employed
-207.8%
Return on sales
-67.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
WVE stock price
How has the Wave Life Sciences stock price performed over time
Intraday
1.02%
1 week
1.44%
1 month
80.95%
1 year
165.12%
YTD
193.47%
QTD
80.73%
Financial performance
How have Wave Life Sciences's revenue and profit performed over time
Revenue
$110.5M
Gross profit
$110.5M
Operating income
-$83.69M
Net income
-$73.49M
Gross margin
100%
Net margin
-66.5%
Wave Life Sciences's net margin has surged by 81% YoY but it has decreased by 22% QoQ
The operating margin has soared by 80% YoY but it has contracted by 18% from the previous quarter
The company's net income rose by 44% YoY but it fell by 19% QoQ
The operating income has grown by 39% YoY but it has contracted by 16% from the previous quarter
Growth
What is Wave Life Sciences's growth rate over time
Valuation
What is Wave Life Sciences stock price valuation
P/E
N/A
P/B
N/A
P/S
17.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.6
Wave Life Sciences's EPS has soared by 57% YoY but it has decreased by 10% from the previous quarter
The equity has plunged by 114% from the previous quarter but it has soared by 93% YoY
The P/S is 180% above the last 4 quarters average of 6.2 but 28% below the 5-year quarterly average of 24.1
Wave Life Sciences's revenue has decreased by 2.1% QoQ
Efficiency
How efficient is Wave Life Sciences business performance
Wave Life Sciences's ROS has soared by 81% YoY but it has decreased by 22% from the previous quarter
WVE's return on assets is up by 50% year-on-year but it is down by 22% since the previous quarter
Dividends
What is WVE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for WVE.
Financial health
How did Wave Life Sciences financials performed over time
The total assets is 2.2% greater than the total liabilities
The quick ratio fell by 27% YoY and by 17% QoQ
WVE's current ratio is down by 25% year-on-year and by 17% since the previous quarter
The equity has plunged by 114% from the previous quarter but it has soared by 93% YoY
Wave Life Sciences's debt has decreased by 18% YoY and by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.